An Incisive, In-depth Analysis on the Companion Animal Speciality Drugs Market
This study offers a comprehensive, 360 degree analysis on the Companion Animal Speciality Drugs market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Companion Animal Speciality Drugs market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.
Key Factors Shaping Companion animal speciality drugs Market
Emergence of new technologies especially in biologics such as recombinant DNA vaccines, Propelling the Growth of Companion Animal Specialty Drugs Market
The animal healthcare market is sub-segmented broadly as drugs for food producing animals and drugs for companion animals. A companion animal primarily refers to cats and dogs, which are domesticated and normally maintained in or near the household of the owner or person caring for them. Pet or companion animals do not refer to a farm animal, or grazing animals such as cattle and sheep etc. A farm animal is a food-producing animal. These produce food items such as meat, eggs, milk, etc. and are not raised or kept within the home premises. A marked shift towards maintaining animal health and welfare has been recorded in developing countries and popularity of compounded drugs has been growing rapidly due to need for easy access to services and affordable veterinary drugs. Emergence of new technologies especially in biologics such as recombinant DNA vaccines for dogs are expected to eventually drive demand for specialties in veterinary vaccines. Recombinant vaccines provide advanced protection to pet animals. Example of one such vaccine is the Recombitek from Sanofi – usually administered to offer broad range protection in canines.
Increasing value and adoption of pet animals to Boost Companion animal speciality drugs Market
Increasing urbanization and increasing spread of isolated family units are expected to increase the growth of the market. Humanization of animals is another important factor, which can increase the growth of companion animal specialty drugs market.
Dogs are the most commonly owned pets in the U.S. (~45 Mn households) while cats are pets of choice in around 30 Mn households in the country. Pet ownership increased from 53.6% to 56.5% over 2009-13 in the U.S.
Increase in geriatric population driving Companion animal speciality drugs market
Globally, adoption of pets among the ageing population has been driving demand for Companion animal speciality drugs services. Baby boomers have been increasingly adopting cats and dogs as pets globally. A clean and hygienic atmosphere at home is essential and preferred by older people. This has led to increased prophylactic medications for pets and the trend is visible globally.
There were more than 3.7 Mn pet owners among the baby boomer generation in the U.S. in 2013. Pet adoption has been increasing mostly for dogs while feline pet ownership rates have remained stagnant globally over the past five years.
Development and Approval of New Drugs is Expected to Increase the Growth of Companion Animal Speciality Drugs Market
Development and approval of new drugs for the treatment of animal diseases, is expected to increase the growth of overall market. For example - In May 2016, the company received marketing approval from the European Medicines Agency (EMA) for Bravecto Spot-On Solution for cats and dogs, and in July 2016, the Company received approval in the U.S. to market the product under the trade name Bravecto Topical.
Companion animal speciality drugs Market Structure Analysis
- Key players are focusing on strengthening their position by the innovation of new products.
- Various manufacturers are targeting Asia and Europe through distribution agreements with local players.
- Some of the key players in the companion animal speciality drugs market include Zoetis Inc., Merck and Co., Inc., Bayer AG, Eli Lily and Co. and Boehringer Ingelheim GmbH among others.
FREQUENTLY ASKED QUESTIONS ABOUT Companion animal speciality drugs MARKET
Which region is expected to lead the global companion animal speciality drugs market?
North America is expected to dominate the global companion animal speciality drugs market. Western Europe is expected to show a significant growth rate in the global companion animal specialty drugs market. Countries in Asia such as Japan is also expected to remain targeted geographies and provide numerous opportunities for regional and key players operating in the companion animal speciality drugs market.
Which product type segment is expected to be most attractive in the companion animal speciality drugs market?
Paraciticides are expected to hold more than 30% of revenue share in the companion animal speciality drugs market owing to its increasing adoption for the treatment of companion animals.
Which distribution channel segment is expected to dominate the companion animal speciality drugs market?
Veterinary clinics in the distribution channel segment represented significant market value share followed by veterinary hospitals. Veterinary clinics are expected to continue their dominance during the forecast period, owing to growing preference among pet owners.
Who are the major players contributing to the growth of companion animal speciality drugs market?
Zoetis Inc., Merck and Co., Inc., Bayer AG, Eli Lily and Co. and Boehringer Ingelheim GmbH are the key players operating in the companion animal speciality drugs market. Introduction of new products and effective marketing are the key strategies practised by major market players to enhance their product portfolio and market share.
How do complications associated with companion animal speciality drugs hamper market growth?
Lack of awareness on animal diseases, declining productivity of R&D on veterinary drugs, increasing cost of innovation dampens R&D investments are the major risk factors expected to hamper the companion animal speciality drugs market growth. Also, matured product portfolios are expected to hinder the growth of companion animal specialty drugs market.
Companion animal speciality drugs Market : Global Industry Analysis 2014-2018 & Opportunity Assessment 2019-2029
A recent market study published by Future Market Insights (FMI) on the Companion animal speciality drugs market offers global industry analysis for 2014-2018 & opportunity assessment for 2019-2029. The report consists of a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the Companion animal speciality drugs market, growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that may make a huge impact on the development of the Companion animal speciality drugs market during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in the Companion animal speciality drugs market in the coming years. The report provides detailed information about the current and future growth prospects of the Companion animal speciality drugs market in the most comprehensive way for better understanding of readers.
Key Segments of Companion animal speciality drugs Market
FMI’s study on the companion animal speciality drugs market offers information divided into five important segments - product type, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
|
Product Type |
Distribution Channel |
Region |
|
|
|
Report Chapters
Chapter 01 – Executive Summary
The report commences with the executive summary of the companion animal speciality drugs market report, which includes the summary of key findings and statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the companion animal speciality drugs market as well as the key trends impacting the market.
Chapter 02 – Market Overview
Readers can find detailed taxonomy and definition of the companion animal speciality drugs market, in this chapter, which helps readers understand basic information about companion animal speciality drugs.
Chapter 03 – Key Market Trends
This section highlights the key trends impacting the companion animal speciality drugs market, which will help readers understand the current trends and their impact on market growth.
Chapter 04 – Key Success Factors
In this chapter, the reader can get information about the key regulations responsible for manufacturing and processing of companion animal speciality drugs products.
Chapter 05 – Global Companion animal speciality drugs Market - Pricing Analysis
The report covers the pricing analysis of the market based on region and other attributes in this chapter. It will help the reader find a comparative analysis of product pricing across different regions of the globe.
Chapter 06 – Global Companion animal speciality drugs Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019–2029
This section explains the global market value analysis and forecast for the companion animal speciality drugs market during the forecast period of 2019-2029. Along with the historical market and opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019–2029).
Chapter 07 – Market Background
This chapter explains the key macroeconomic factors that are expected to influence the growth of the Companion animal speciality drugs market over the forecast period. The chapter also highlights macroeconomic factors and major forecast factors that will shape market growth. Besides, it provides key dynamics of the companion animal speciality drugs market, which include drivers, restraints, and opportunity analysis. This chapter is expected to enable readers to understand the factors that are propelling growth of the companion animal speciality drugs market, as well as those that are likely to hamper growth of the companion animal speciality drugs market. The opportunity analysis for the companion animal speciality drugs will help readers understand the market opportunities, based on which they can plan their strategies.
Chapter 08 – Global Companion animal speciality drugs Market Analysis (2014-2018) & Opportunity Assessment (2019-2029), By Product Type
Based on product type, the companion animal speciality drugs market is segmented into antibiotics, anti-inflammatory drugs, parasiticides, heartworm, behavioral products, nutritional drugs, anti-obesity drugs, skin care products and vaccines. In this chapter, readers can find information and analysis of the market by different product type of companion animal speciality drugs and their growth over the forecast period.
Chapter 09 – Global Companion animal speciality drugs Market Analysis 2014-2018 & Opportunity Assessment, 2019-2029, by Distribution Channel
Based on distribution channel, the companion animal speciality drugs market is segmented into veterinary hospitals, veterinary clinics and pharmacies and drug stores . In this chapter, readers can find information on market attractiveness analysis based on the end user.
Chapter 10 – Global Companion animal speciality drugs Market Analysis 2014-2018 & Opportunity Assessment, 2019-2029, by Region
This chapter explains how the Companion animal speciality drugs market will grow across various geographic regions such as North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa (MEA).
Chapter 11 – North America Companion animal speciality drugs market Analysis 2014-2018 & Opportunity Assessment, 2019-2029
This chapter includes a detailed analysis of the growth of the North America Companion animal speciality drugs market along with the country-wise assessment including the U.S. and Canada. Readers can also find key takeaways of this region, and market growth based on product type, by procedure, animal type, end user, and country of Companion animal speciality drugs in the North America region.
Chapter 12 – Latin America Companion animal speciality drugs Market Analysis 2014-2018 & Opportunity Assessment, 2019-2029
This chapter includes the growth prospects of the Companion animal speciality drugs market in leading countries such as Brazil, Mexico, Argentina, and the rest of Latin America. Readers can find thorough information about the growth parameters of the Latin America Companion animal speciality drugs market during the period 2019-2029.
Chapter 13 –Europe Companion animal speciality drugs market Analysis 2014-2018 & Opportunity Assessment, 2019-2029
Important growth prospects of the Companion animal speciality drugs market based on product type, by procedure, animal type, end user, and country in several European countries such as the U.K., Germany, France, Italy, Spain, Russia, BENELUX, and Rest of Europe are included in this chapter.
Chapter 14 – East Asia Companion animal speciality drugs market Analysis 2014-2018 and Forecast 2019-2029
Detailed information about factors such as incremental opportunity, Y-O-Y growth, and regional trends that are impacting the growth of the East Asia Companion animal speciality drugs market are included in this chapter. It also includes the growth prospects of the Companion animal speciality drugs market in leading East Asian countries such as China, Japan, and South Korea.
Chapter 15 – South Asia Companion animal speciality drugs market Analysis 2014-2018 and Forecast 2019-2029
India, Indonesia, Malaysia, Thailand, and the Rest of South Asia are the leading countries/regions in South Asia that are the prime subjects of assessment to obtain the growth prospects of the South Asia Companion animal speciality drugs market. In this chapter. Readers can find thorough information about the growth parameters of the South Asia Companion animal speciality drugs market during the period.
Chapter 16 – Oceania Companion animal speciality drugs market Analysis 2014-2018 and Forecast 2019-2029
This chapter consists of important parameters that have a huge impact on the growth of the Companion animal speciality drugs market in Oceania, based on market segmentation, during the forecast period. The chapter also provides an overview of the market growth of Oceania Companion animal speciality drugs market.
Chapter 17 – MEA Companion animal speciality drugs market Analysis 2014-2018 & Opportunity Assessment, 2019-2029
This chapter provides information on how the Companion animal speciality drugs market will grow in the major countries in the MEA region such as GCC Countries, South Africa, Turkey, Northern Africa and Rest of MEA during the period.
Chapter 18 – Market Structure Analysis
This chapter covers the market analysis of competitors based on revenue tiers, single point of view of the portfolio across industry segments, and their relative market position.
Chapter 19 – Competition Analysis
In this chapter, readers can find a comprehensive list of all the leading stakeholders in the Companion animal speciality drugs market, along with detailed information about each company, including company overview, revenue shares, strategic overview, and recent company developments. Players featured in the Companion animal speciality drugs market report include Zoetis Inc., Merck and Co., Inc., Bayer AG, Eli Lily and Co. and Boehringer Ingelheim GmbH among others.
Chapter 20 – Assumptions and Acronyms Used
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.
Chapter 21 – Research Methodology
This chapter helps readers understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the Companion animal speciality drugs market.
Sources and Primary Research Splits (%)
|
Industry Interactions
|
|
|
References Catalogue
|
|
COVID -19 : Impact Analysis
Request the coronavirus impact analysis across industries and markets
Request Covid -19 ImpactGet in touch
Our Clients
CASE STUDIES
See how our work makes an impact.
At FMI, we design strategies that are adaptive, impactful, and implementable.